Clinical Trial
Published on 16 Feb 2023
The rapid inhibition of B-cell activation markers by belimumab was associated with disease control in systemic lupus erythematosus patients
in Inflammation Pharmacology
- 3,179 views
Clinical Trial
Published on 16 Feb 2023
in Inflammation Pharmacology
Original Research
Published on 15 Feb 2023
in Inflammation Pharmacology
Original Research
Published on 15 Feb 2023
in Inflammation Pharmacology
Review
Published on 15 Feb 2023
in Inflammation Pharmacology
Systematic Review
Published on 14 Feb 2023
in Inflammation Pharmacology
Review
Published on 14 Feb 2023
in Inflammation Pharmacology
Original Research
Published on 13 Feb 2023
in Inflammation Pharmacology
Systematic Review
Published on 13 Feb 2023
in Inflammation Pharmacology
Editorial
Published on 09 Feb 2023
in Inflammation Pharmacology
Review
Published on 07 Feb 2023
in Inflammation Pharmacology
Editorial
Published on 02 Feb 2023
in Inflammation Pharmacology
Systematic Review
Published on 30 Jan 2023
in Inflammation Pharmacology
Review
Published on 25 Jan 2023
in Inflammation Pharmacology
Mini Review
Published on 23 Jan 2023
in Inflammation Pharmacology
Mini Review
Published on 20 Jan 2023
in Inflammation Pharmacology
Original Research
Published on 20 Jan 2023
in Inflammation Pharmacology